Carregant...
The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritis
Patients with rheumatoid arthritis (RA) are at an increased risk of cardiovascular disease (CVD). Treatment with tumor necrosis factor inhibitors improves both joint symptoms associated with RA and also CVD risk. This exploratory analysis of a phase 4 study evaluated changes in metabolic risk factor...
Guardat en:
| Publicat a: | Clin Rheumatol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer London
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5118390/ https://ncbi.nlm.nih.gov/pubmed/27704313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-016-3422-7 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|